14 days of Premium, free.
Every scanner with live hit rates + the Market Pulse risk flag that tells you when to get defensive. No card required.
Start trial →
Tradestie Institutional Equity Comparison Engine · Market Close Nov 16, 2026
EPOW vs VTAK: Which Stock Is the Better Buy Now?
Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.
As of Nov 16, 2026, Catheter Precision, Inc. (VTAK) is the stronger overall head-to-head candidate over Sunrise New Energy Co., Ltd Class A (EPOW) in the Tradestie Institutional Equity Comparison Engine, winning 5–2 core matrix metrics and 2–2 across our 6-pillar institutional scorecard (led by Growth & Scale, Profitability & Quality). EPOW carries a Unified Composite Score of 47.1/100 (HOLD) at $3.30 (N/M Forward P/E, -34.5% operating margin), whereas VTAK carries 58.1/100 (HOLD) at $0.15 (N/M Forward P/E, -388.1% operating margin).
Technical & Structure Timing Caution: EPOW trades in a Neutral technical trend (UNCLASSIFIED options phase, RSI 47.2); meanwhile VTAK is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 33.2). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on EPOW vs VTAK. Trailing 12-month operating profitability (EPOW -34.5% vs VTAK -388.1%) and valuation multiples (EPOW N/M vs VTAK N/M Forward P/E) are benchmarked directly in Pillar 4 below.
Competes within the Medical Devices value chain with $548,639 market capitalization and -388.1% operating margin.
OpEx & R&D ReinvestmentN/A
90D Engineering Disclosures0 Published
Investor FAQ EPOW vs VTAK Key Questions & Quantitative Answers
As of Nov 16, 2026, Catheter Precision, Inc. (VTAK) is the stronger overall head-to-head candidate over Sunrise New Energy Co., Ltd Class A (EPOW) in the Tradestie Institutional Equity Comparison Engine, winning 5–2 core matrix metrics and 2–2 across our 6-pillar institutional scorecard (led by Growth & Scale, Profitability & Quality). EPOW carries a Unified Composite Score of 47.1/100 (HOLD) at $3.30 (N/M Forward P/E, -34.5% operating margin), whereas VTAK carries 58.1/100 (HOLD) at $0.15 (N/M Forward P/E, -388.1% operating margin). Technical & Structure Timing Caution: EPOW trades in a Neutral technical trend (UNCLASSIFIED options phase, RSI 47.2); meanwhile VTAK is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 33.2). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
VTAK leads the Growth & Scale pillar: EPOW posts -56.8% YoY revenue growth and +0.0% YoY earnings growth on $46M TTM revenue (-12.6% gross margin, -34.5% operating margin), compared with VTAK at +380.7% YoY revenue growth and +0.0% YoY earnings growth on $1.9M TTM revenue (47.7% gross margin, -388.1% operating margin). On trailing 12-month operating scale, EPOW generates $46M in USD-normalized revenue versus $1.9M for VTAK. In operating R&D and SG&A reinvestment, EPOW deploys 21.9% of Rev ($10M) (0 90-day corporate R&D disclosures) versus N/A (0 disclosures) for VTAK.
EPOW and VTAK trade at balanced relative valuation multiples. EPOW trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and 0.2x EV/Revenue (-20.8% EBITDA margin), whereas VTAK trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and 0.3x EV/Revenue (unreported EBITDA margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against EPOW (-123.5% ROE) versus VTAK (-111.3% ROE) capital efficiency.
In options market volatility and institutional positioning, EPOW carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (-2.79β · 147% Vol realized risk). By comparison, VTAK carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.19β · 76% Vol realized risk).
Cross-Compare 1-Click Peer Rivalries & Single-Stock Research
Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 16, 2026. For educational research only; not investment advice.